These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Clinical applications of assessment of airway inflammation using induced sputum. Pavord ID; Sterk PJ; Hargreave FE; Kips JC; Inman MD; Louis R; Pizzichini MM; Bel EH; Pin I; Grootendorst DC; Parameswaran K; Djukanović R Eur Respir J Suppl; 2002 Sep; 37():40s-43s. PubMed ID: 12361362 [No Abstract] [Full Text] [Related]
10. [Clinical application of induced and spontaneous sputum in asthma and chronic obstructive pulmonary disease]. Antus B Orv Hetil; 2012 Nov; 153(47):1847-54. PubMed ID: 23160075 [TBL] [Abstract][Full Text] [Related]
11. Induced sputum eosinophil cationic protein (ECP) measurement in asthma and chronic obstructive airway disease (COAD). Gibson PG; Woolley KL; Carty K; Murree-Allen K; Saltos N Clin Exp Allergy; 1998 Sep; 28(9):1081-8. PubMed ID: 9761011 [TBL] [Abstract][Full Text] [Related]
12. Comparison of cellular composition of induced sputum analyzed with Wright staining and immunocytochemistry. Lemière C; Taha R; Olivenstein R; Hamid Q J Allergy Clin Immunol; 2001 Oct; 108(4):521-3. PubMed ID: 11590375 [TBL] [Abstract][Full Text] [Related]
13. Assessment of a rapid liquid-based cytology method for measuring sputum cell counts. Martin MJ; Lee H; Meakin G; Green A; Simms RL; Reynolds C; Winters S; Shaw DE; Soomro I; Harrison TW Thorax; 2016 Dec; 71(12):1163-1164. PubMed ID: 27503234 [TBL] [Abstract][Full Text] [Related]
14. Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma-COPD overlap. Gao J; Zhou W; Chen B; Lin W; Wu S; Wu F Int J Chron Obstruct Pulmon Dis; 2017; 12():2703-2710. PubMed ID: 28979112 [TBL] [Abstract][Full Text] [Related]
15. Comparison of two methods of processing induced sputum: selected versus entire sputum. Belda J; Parameswaran K; Hargreave FE Am J Respir Crit Care Med; 1998 Aug; 158(2):680-2. PubMed ID: 9700151 [No Abstract] [Full Text] [Related]
16. Determination of the inflammatory component of airway diseases by induced sputum cell counts: use in clinical practice. Moritz P; Steidle LJ; Felisbino MB; Kleveston T; Pizzichini MM; Pizzichini E J Bras Pneumol; 2008 Nov; 34(11):913-21. PubMed ID: 19099097 [TBL] [Abstract][Full Text] [Related]
18. Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma. in 't Veen JC; de Gouw HW; Smits HH; Sont JK; Hiemstra PS; Sterk PJ; Bel EH Eur Respir J; 1996 Dec; 9(12):2441-7. PubMed ID: 8980951 [TBL] [Abstract][Full Text] [Related]
19. Comparison of two methods of processing induced sputum: selected versus entire sputum. Spanevello A; Beghé B; Bianchi A; Migliori GB; Ambrosetti M; Neri M; Ind PW Am J Respir Crit Care Med; 1998 Feb; 157(2):665-8. PubMed ID: 9476888 [TBL] [Abstract][Full Text] [Related]
20. [Value of sputum analysis in the management of inflammatory airway diseases]. Mazzei JA; Rocher AE; Palaoro L Medicina (B Aires); 2012; 72(4):332-8. PubMed ID: 22892087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]